Robert C. Smallridge

Author

Also Known As

Alexander J. Lazar, Carmen Behrens, J. R. Molina, Jaffer A. Ajani, Jolanta Bondaruk, Ju Dong Yang, Kendall J. Schick, Lizhi Zhang, Melissa Stanton, R C Smallridge

356

Publications

50.9K

Citations

H-Index

180

Concepts

All Affiliations

Walter Reed Army Institute of Research Mayo Clinic in Florida Jacksonville College Mayo Clinic WinnMed

About

Robert C. Smallridge is an author at Walter Reed Army Institute of Research specializing in medicine, endocrinology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	75	5.3K
2	Health Sciences	11	11	888
3	Natural Sciences	5	5	178
4	Education	1	1	52
5	Engineering	1	1	895

Robert C. Smallridge

148

Publications

15.3K

Citations

H-Index

Page 1

	Year	Citations
Integrated Genomic Characterization of Papillary Thyroid Carcinoma Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy, Cell	2014	3K
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer Robert C. Smallridge, Kenneth B. Ain, L. Sylvia, Thyroid	2012	921
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Release of Multiple Hormones by a Direct Action of Interleukin-1 on Pituitary Cells Edward W. Bernton, Judith E. Beach, John W. Holaday, Science Pituitary CellsHuman GrowthImmunologyImmune RegulationHormone Secretion	1987	672
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification Rebecca E. Schweppe, Joshua Klopper, Christopher Korch, The Journal of Clinical Endocrinology & Metabolism	2008	563
Thyrotropin-Secreting Pituitary Tumors* Paolo Beck‐Peccoz, Françoise Brücker-Davis, Luca Persani, Endocrine Reviews	1996	448
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study Keith C. Bible, Vera J. Suman, Julian R. Molina, The Lancet Oncology Thyroid CancersOncologyMedicineThyroid DiseaseConsortium Study	2010	414
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018 Robert I. Haddad, Christian Nasr, Lindsay Bischoff, Journal of the National Comprehensive Cancer Network	2018	364

Page 1